Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1079 of 5804
-
HIV Self-Test kits and counseling aim to boost prevention for new moms and partners
Prevention Recruiting nowThe purpose of this study is to test the feasibility and acceptability of a combination intervention to promote HIV self-testing (HIVST) for Partners and PrEP uptake for HIV-uninfected Postpartum Women ("H4P"). H4P includes evidence-based cognitive behavioral therapy (CBT) strate…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
Tiny tube could tame glaucoma without daily drops
Disease control Recruiting nowThe purpose of this study is to collect safety and performance data on the PRESERFLO™ MicroShunt XI in patients diagnosed with primary open angle glaucoma who are inadequately controlled on maximum tolerated medical therapy with intraocular pressure ≥18 mmHg and ≤35 mmHg and/or w…
Sponsor: Santen SAS • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New laser zaps eye pressure in seconds for glaucoma patients
Disease control Recruiting nowThis study is a single-site, single-arm, prospective, observational study of IOP reduction after DSLT. Subjects will be assessed up to 12 months post-operatively. Clinical evaluations will include IOP and number of glaucoma medications.
Sponsor: Mann Eye Institute • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New study aims to cut opioid use after hip surgery without sacrificing pain relief
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate whether an opioid-sparing postoperative pain regimen can reduce opioid consumption and maintain effective pain control in adults undergoing anterior total hip arthroplasty for osteoarthritis. The main questions it aims to answer are…
Phase: PHASE3 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Teplizumab's Real-World impact on type 1 diabetes under scrutiny
Disease control Recruiting nowThis is an observational, prospective cohort study designed to evaluate the outcomes after teplizumab treatment in participants with Stage 2 Type 1 Diabetes (T1D) for delaying the onset of Stage 3 T1D. The study will monitor participants receiving teplizumab as part of routine cl…
Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New lupus drug anifrolumab put to the test in everyday clinics
Disease control Recruiting nowVIOLET is a prospective, single-arm, multi-centre, non-interventional study (NIS) evaluating real-world clinical and patient-reported outcome (PRO) data in adult patients who are initiated on subcutaneous anifrolumab treatment of systemic lupus erythematosus (SLE) in line with th…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New psoriasis drug shows promise in Mid-Stage trial
Symptom relief Recruiting nowThis is a multicenter, randomized, double-blinded, placebo-controlled, dose-range finding study to evaluate the efficacy and safety of ORKA-002 in adult participants with moderate-to-severe plaque psoriasis.
Phase: PHASE2 • Sponsor: Oruka Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Can a rapid test help doctors pick the right antibiotic faster?
Knowledge-focused Recruiting nowThe ACT-FAST study aims to compare commercially available Rapid Antimicrobial Susceptibility Testing (R-AST) tools with the current standard of care for patients with Bloodstream Infections (BSI). The primary objective is to evaluate whether "early targeted" antibiotic prescripti…
Phase: NA • Sponsor: Istituto Clinico Humanitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Dietary formula may shield menopausal Women's brains from Obesity-Linked decline
Prevention Recruiting nowPeople living with obesity have a higher risk of late-life cognitive decline and developing dementia. In women, the risk of cognitive decline may further raise during the menopausal transition, a period of substantial hormonal and metabolic changes. Recent studies suggest that a…
Phase: NA • Sponsor: Max Planck Institute for Human Cognitive and Brain Sciences • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
New pill could stop scalp scarring and hair loss
Disease control Recruiting nowThis study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with lichen planopilaris
Phase: PHASE2, PHASE3 • Sponsor: Priovant Therapeutics, Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New drug hopes to tame rare Gut-Heart disease in toddlers
Disease control Recruiting nowThis study is researching a drug called pozelimab (called "study drug"). The main aim of this study is to monitor the safety and tolerability of the study drug. The study is focused on young children 1 to 5 years of age, who have CHAPLE disease. CHAPLE is a very rare hereditary …
Phase: PHASE4 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New heart mapping technique could make VT ablation safer
Disease control ENROLLING_BY_INVITATIONVentricular tachycardia (VT) is a leading cause of death and suffering in the Veteran population. Currently, ablation procedures are performed to destroy the diseased tissue that causes this problem. This study will test to see if an experimental strategy of only targeting region…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Tiny scope, big hope: new surgery aims to ease back pain without the usual side effects
Symptom relief Recruiting nowLumbar spinal stenosis (LSS), a common degenerative lumbar condition characterized by low back pain, leg pain, and neurogenic claudication, significantly impairs patients' quality of life. Its prevalence continues to rise with the aging population. For patients who do not respond…
Phase: NA • Sponsor: The Third Affiliated Hospital of Southern Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New study tests if pulmonary rehab can prevent Long-Term lung damage after TB
Disease control Recruiting nowIndividual-level, unblinded randomized controlled trial of an 8-week (short arm) or 24-week (extended arm) pulmonary rehabilitation program, relative to standard of care, to prevent post-tuberculosis respiratory morbidity. Randomization will occur in a 1:1:1 ratio at the initiati…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New CAR-T therapy targets antibodies blocking Life-Saving transplants
Disease control Not yet recruitingThis is an early-stage, open-label clinical study of CD19-BCMA dual nanobody based CAR-T Cell desensitization therapy for patients positive for Donor-Specific Antibodies. Enrolled subjects will participate in an early clinical study using the traditional "3+3" dose escalation des…
Phase: PHASE1, PHASE2 • Sponsor: Chang Yingjun • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Virtual reality game shows promise for stroke and brain injury recovery
Disease control Not yet recruitingStroke and traumatic brain injury frequently result in persistent upper and lower limb motor impairment. While conventional rehabilitation improves outcomes, patient adherence and training intensity remain limiting factors. Immersive virtual reality (VR)-based therapy may enhance…
Phase: NA • Sponsor: Reuth Rehabilitation Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Modified virus takes on tough tumors in early trial
Disease control Recruiting nowVG2062 is a Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 Injection. This Phase I study will be conducted in herpes simplex virus (HSV) -seropositive subjects with advanced malignant solid tumors that are refractory to conventional therapies. This is an open label stud…
Phase: PHASE1 • Sponsor: Shanghai Virogin Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Poop pills to treat brain fog in the ICU?
Disease control Recruiting nowDelirium in the intensive care unit (ICU) is a prevalent and serious neurological complication among critically ill patients, with large multicenter studies reporting an incidence of 30% to 80%, particularly in those requiring mechanical ventilation. Delirium is not only associat…
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Placental patch could speed healing of stubborn leg wounds
Disease control Recruiting nowA Prospective, Multi-Center, Randomized Controlled Clinical Trial Evaluating NuShield® plus Standard of Care (SOC) versus Standard of Care (SOC) alone in the Management of Non-Healing Venous Leg Ulcers (VLUs). The study is a prospective, multi-center, open label, RCT designed to …
Phase: NA • Sponsor: Organogenesis • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New tracer could sharpen lung cancer PET scans
Diagnosis Recruiting nowLung malignant tumors are a significant health threat with high incidence and mortality rates, and molecular imaging is crucial for early diagnosis, staging, prognosis evaluation, and therapeutic efficacy assessment. 18F-FDG PET imaging is widely used, but has limitations. CDH3 i…
Sponsor: Peking University People's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC